期刊文献+

奥沙利铂联合卡培他滨治疗老年性胃癌的临床效果分析 被引量:6

Clinical Analysis of Oxaliplatin Combined with Capecitabine in the Treatment of Senile Gastric Cancer
原文传递
导出
摘要 目的研究奥沙利铂联合卡培他滨治疗老年性胃癌的临床效果。方法选取在某院接受治疗的老年性胃癌患者68例,根据患者的入院顺序,将患者平均分为2组,对照组患者34例,其接受奥沙利铂+叶亚酸钙+氟尿嘧啶治疗,观察组患者34例,其接受奥沙利铂联合卡培他滨治疗。结果经过治疗后,观察组患者有2例为完全缓解、15例为部分缓解,治疗有效率为50.00%,对照组患者的治疗有效率为35.29%,两组数据对比,差异有统计学意义(P<0.05);观察组患者不良反应发生率与对照组对比,差异有统计学意义(P<0.05)。结论老年性胃癌患者接受奥沙利铂联合卡培他滨,能够促进患者病情的好转,不良反应少,值得推广应用。 OBJECTIVE To study the clinical effect of oxaliplatin combined with capecitabine in the treatment of senile gastric cancer.METHODS 68 cases of elderly gastric cancer patients who received treatment in a hospital were selected.According to the order of admission,the patients were divided into 2 groups on average.34 patients in the control group were treated with oxaliplatin+calcium hyalite+fluorouracil,and 34 patients in the observation group were treated with oxaliplatin combined with capecitabine.RESULTS after treatment,2 patients in the observation group had complete response,15 patients had partial response,and the effective rate was 50.00%.The effective rate in the control group was 35.29%.The difference between the two groups was statistically significant(P<0.05).The incidence of adverse reactions in the observation group was significantly different from that in the control group(P<0.05).CONCLUSION the combination of oxaliplatin and capecitabine in elderly patients with gastric cancer can promote the improvement of the patient’s condition with fewer adverse reactions,which is worthy of promotion and application.
作者 范翠琼 童艳丽 曾泗宇 杨水源 FAN Cuiqiong;TONG Yanli;ZENG Siyu;YANG Shuiyuan(The Second People’s Hospital of Guangdong Province,Guangzhou 510317,China)
出处 《今日药学》 CAS 2019年第3期189-191,共3页 Pharmacy Today
基金 广东省中医药局科研项目(20191014)
关键词 奥沙利铂 卡培他滨 胃癌 老年 临床效果 oaliplatin capecitabine gastric cancer old age clinical effect
  • 相关文献

参考文献7

二级参考文献60

  • 1方悦,曹渊,秦蓉,沈慧玲,许文林.汉防己甲素诱导人胃癌BGC-823细胞自噬和凋亡的作用及机制[J].山东医药,2013,53(30):1-5. 被引量:6
  • 2吴俊东,庄业忠,黄文河,黄棉生,王伟峰,许慕明.思他宁在胃肠道肿瘤所致恶性肠梗阻非手术治疗中的应用[J].实用癌症杂志,2007,22(2):188-190. 被引量:10
  • 3王运红,杨瑞青,郑法德,等.卡培他滨联合奥沙利铂治疗晚期结肠癌的疗效观察[J].海南医学院学报,2012,17(7) :123.
  • 4Casaretto L, Sousa PL, Mari JJ. Chemotherapy versus support cancer treatment in advanced gastric cancer: a meta-analysis [ J]. Braz J Med Biol Res, 2006, 39(4) :431-440. W.
  • 5agner AD, Gmthe W, I-Iaerting J, et al. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data [ J ]. J Clin Oncol, 2006, 24 ( 18 ) : 2903-2909. DOI: 10.1200/JCO.2005.05.0245.
  • 6Chong G, Cunningham D. Can cisplatin and infused 5-fluorouracil be replaced by oxaliplatin and capecitabine in the treatment of advanced oesophagogastric cancer? The REAL 2 trial [ J ]. Clin Oncol (R Coil Radiol) , 2005, 17(2) :79-80.
  • 7Zhang SH, Zhang H, He HW, et al. Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma [ J]. Cancer Chemother Pharmacol, 2013, 72 (4) : 777-788.DOI : 10.1007/s00280-013-2253-3.
  • 8Sakata K, Someya M, Matsumoto Y, et al. Gimeracil, an inhibitor of dihydropyrimidine dehydrogenase, inhibits the early step in homologous recombination [ J ]. Cancer Sci, 2011, 102 (9) : 1712- 1716.DOI : 10.1111/j. 1349-7006.2011.02004.x.
  • 9Van Cutsem E, Moiseyenko VM, Tjulandin S, et al. Phase BIstudy of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group [ J]. J Clin Oncol, 2006, 24 ( 31 ) : 4991-4997. DOI : 10.1200/JCO.2006.06.8429.
  • 10Schtiller J, Cassidy J, Dumont E, et al. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients [ J ]. Cancer Chemother Pharmacol, 2000, 45 (4) : 291-297.

共引文献163

同被引文献88

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部